Addressing Barriers to Molecular Testing in NSCLC
Reactions to low rates of molecular testing for patients with non-small cell lung cancer in community settings.
Read More
The Importance of Clinical Trials in Non-Small Cell Lung Cancer
A brief discussion on the importance of enrolling in clinical trials and when that may be an option in non-small cell lung cancer.
NSCLC: What Are Biomarkers and How Do They Affect Treatment?
An in-depth explanation of biomarkers in non-small cell lung cancer, particularly how they can affect the disease and treatment options.
Undergoing Genetic Testing for Non-Small Cell Lung Cancer
Allison Collins reflects on the genetic testing she underwent after receiving a non-small cell lung cancer diagnosis and describes the treatment options presented to her at that time.
Educated Patient® Multiple Myeloma Summit in Partnership with Sylvester Comprehensive Cancer Center, University of Miami
View the full CURE® Educated Patient® Multiple Myeloma Summit in Partnership with Sylvester Comprehensive Cancer Center, University of Miami on demand.
CURE Media Group Announces 2021 Lung Cancer Heroes® Award Winners
The second annual awards program will honor three heroes for their contributions to the lung cancer community.
NSCLC: Understanding Staging and Diagnostic Testing
Dr. Vamsidhar Velcheti provides an expert’s insight on the testing and staging that must be performed during a diagnosis of non-small cell lung cancer.
Predictive and Prognostic Biomarkers in NSCLC
Drs. Charu Aggarwal and Hossein Borghaei comment on the importance of having predictive and prognostic biomarkers in non-small cell lung cancer and highlight their approaches to testing patients prior to initiating therapy.
Navigating Emotional Response to a Lung Cancer Diagnosis
Considerations for the emotional impact of a lung cancer diagnosis and how patients can be supported during their treatment journey.
Education on NSCLC Symptoms and Risk Factors
Approaches that can help lung oncologists discuss symptoms and risk factors of non-small cell lung cancer with patients and their loved ones.
Receiving a Diagnosis of Non-Small Cell Lung Cancer
Allison Collins describes her diagnosis with KRAS-positive non-small cell lung cancer and the symptoms that led her to seek medical attention.
Resources and Tools for Non-Small Cell Lung Cancer
Ms. Addario, lung cancer survivor, encourages patients with non-small cell lung cancer to use all the resources and tools that are available to them.
Overcoming Barriers to Lung Cancer Screening
Challenges surrounding the screening of high-risk patients for lung cancer in the community.
Advocacy and Education for Biomarker Testing in Non-Small Cell Lung Cancer
Ms. Addario shares the promising hope for patients with lung cancer and describes the steps in the process of biomarker testing for patients with lung cancer.
Novel-Based Treatment Approaches in NSCLC
Advances in non-small cell lung cancer that have helped lung oncologists make more informed treatment decisions with patients.
Treatment Targets in Non-Small Cell Lung Cancer
Treating patients with lung cancer by identifying specific biomarkers to use the correct combination therapy and what it means for a biomarker to be actionable.
Support Networks for Patients With Multiple Myeloma
Shared insight on the importance of support networks, both medical and personal, in the treatment journey of multiple myeloma.
Learning How to Live With Multiple Myeloma
Taking her own experience with multiple myeloma into account, Marcella shares how she learned to live with the disease by practicing good health and communication habits.
Educated Patient® Webinar: Treatment and Care for Thyroid Cancer
View the full CURE® Educated Patient® Webinar: Treatment and Care for Thyroid Cancer on demand.
Multiple Myeloma: Working Together to Decide on Treatment
A discussion of how patients and physicians can work together to decide on the best individualized treatment option for multiple myeloma.
Relapsed Multiple Myeloma: Finding the Best Treatment Option
Kenneth Shain, M.D., Ph.D., and Marcella reflect on how she didn’t tolerate her second line of therapy for multiple myeloma well and moved to a novel treatment regimen thereafter.
Multiple Myeloma: Maintenance Therapy and Observation
Kenneth Shain, M.D., Ph.D., discusses the use of maintenance therapy and observation in multiple myeloma as Marcella shares her own experience with multiple myeloma remission.
Undergoing Transplant for Multiple Myeloma
Marcella, accompanied by Kenneth Shain, M.D., Ph.D., shares her experience in preparing for autologous stem cell transplant to treat her multiple myeloma.
Multiple Myeloma: Receiving First-Line Therapy
Kenneth Shain, M.D., Ph.D., and Marcella reflect on the first line of therapy she received for multiple myeloma in light of her response and reaction to certain treatments.
Reacting to a Diagnosis of Multiple Myeloma
A brief discussion of how Marcella reacted to her diagnosis of multiple myeloma and the importance of support networks for patients.
Educated Patient® MPN Summit: August 28, 2021
View the full CURE Educated Patient MPN Summit on demand.
Confirming a Diagnosis of Multiple Myeloma
Marcella shares how she met her diagnosis of multiple myeloma as Kenneth Shain, M.D., Ph.D., considers her experience in relation to other patients with multiple myeloma.
Educated Patient® Webinar: Individualized Treatment for Small Cell Lung Cancer
View the full CURE® Educated Patient® Webinar: Individualized Treatment for Small Cell Lung Cancer on demand.
Educated Patient® Webinar: Stomach Cancer 101 Series: Part II – Treatment
View the full CURE® Educated Patient® Webinar: Stomach Cancer 101 Series: Part II - Treatment on demand.
CURE® Media Group Opens Nominations for the 2021 MPN Heroes® Recognition Program
Since 2013, the MPN Heroes® program has honored people and organizations that have dedicated themselves to improving the lives of those with myeloproliferative neoplasms (MPN).